Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.175 USD | -10.56% | -7.07% | +153.52% |
08/05 | Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study | CI |
16/04 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+153.52% | 4.57Cr | |
+30.06% | 68TCr | |
+30.34% | 57TCr | |
-3.98% | 36TCr | |
+18.22% | 33TCr | |
+4.13% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+6.85% | 17TCr |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study